EVAg

The service aims at offering the possibility to evaluate the outcome of an infection by a SARS-CoV-2 strain or variant in a susceptible cell line : evaluation of the susceptibility of a cell line, evaluation of the infectivity of a variant compared to a reference variant, evaluation of the effect of infection on a cellular pathway etc... The project can be refined upon request

Freeze-dried SARS-CoV-2 virus, strain SARS-CoV-2/2021/FR/0610 (Lineage B 1.617.2, Delta) France 2021, complete genome sequence. Presence of spike mutation A222V and absence of spike mutation Y145H.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1572 in the spike coding sequence) of the SARS-CoV-2 alpha variant (B.1.1.7) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1517 in the spike coding sequence) of the SARS-CoV-2 beta variant (B.1.351 )and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1581 in the spike coding sequence) of the SARS-CoV-2 BavPat1 strain (D614G) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1581 in the spike coding sequence) of the SARS-CoV-2 delta variant (B.1.617.2) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD of the SARS-CoV-2 gamma variant (P.1) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2020/FR/702, France 2020, complete genome sequence. NB: this virus contains the G614 european mutation in the spike sequence

Panel of Freeze-dried SARS-CoV-2 variants (Europe, UK, South Africa, Brazil, Delta). Please note Brazilian variant can not be supplied to private entities

Freeze-dried SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-503 (lineage P.1, ex Brazil) Japan 2021, complete genome sequence. Please note this product can not be supplied to private entities

Freeze-dried SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-501 (lineage P.1, ex Brazil) Japan 2021, complete genome sequence. Please note this product can not be supplied to private entities

genomic RNA from culture supernatant of UVE/SARS-CoV-2/2021/FR/1299-ex SA. 100µL containing E+04 copies/µl provided in AVE buffer + RNA carrier.

Freeze-dried SARS-CoV-2 virus, strain SARS-CoV-2/2021/FR/4700 (lineage A27-like), France 2021, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/FR/1299-ex SA (lineage B 1.351, ex South Africa) France 2021, complete genome sequence.

genomic RNA from culture supernatant of SARS-CoV-2/2021/FR/7b (lineage B 1. 1 .7, ex UK). 100µL containing 1.25E+04 copies/µl provided in AVE buffer + RNA carrier.

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/FR/7b (lineage B 1. 1 .7, ex UK) France 2021, complete genome sequence.

Freeze-dried SARS-CoV-2 virus, isolate England/MIG457/2020 (lineage B.1.1.7), England 2020, complete genome. Please note this product can not be supplied to private entities

Freeze dried SARS-CoV-2 virus, strain UVE/SARS-CoV2/2020/FR/ISA_D614 generated by ISA method. It contains the original D614 residue on the Spike protein

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the N (CUB) gene, for 100 Rxns (Target designed by Charité Universitätsmedizin Berlin). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp (IP2/IP4) gene, for 100 Rxns (Target designed by Institut Pasteur: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2) The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp gene, for 25 Rxns (Target designed by Charité Universitätsmedizin Berlin). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the E gene, for 100 Rxns (Target designed by Charité Universitätsmedizin Berlin ; https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)